Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009
Wed, August 19, 2009
Tue, August 18, 2009
Mon, August 17, 2009
Sun, August 16, 2009
Fri, August 14, 2009
Thu, August 13, 2009
Wed, August 12, 2009
Tue, August 11, 2009
Mon, August 10, 2009
Fri, August 7, 2009
Thu, August 6, 2009
Wed, August 5, 2009
Tue, August 4, 2009
Mon, August 3, 2009
Sat, August 1, 2009
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009
Sat, July 25, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Sun, July 19, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009
Mon, July 13, 2009
Fri, July 10, 2009
Thu, July 9, 2009
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009
Mon, June 29, 2009
Fri, June 26, 2009
Thu, June 25, 2009

AspenBio Pharma, Inc.: AspenBio Pharma to Present at the Canaccord Adams 29th Annual Global Growth Conference


//health-fitness.news-articles.net/content/2009/ .. -adams-29th-annual-global-growth-conference.html
Published in Health and Fitness on Thursday, July 30th 2009 at 7:13 GMT, Last Modified on 2009-07-30 07:13:34 by Market Wire   Print publication without navigation


CASTLE ROCK, CO--(Marketwire - July 30, 2009) - AspenBio Pharma, Inc. (NASDAQ: [ APPY ]), an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, has been invited to present at the Canaccord Adams 29th Annual Global Growth Conference. The conference will be held at the InterContinental Boston on August 11-13, 2009.

Company management is scheduled to present on Tuesday, August 11, 2009 at 8:00 a.m. Eastern Time with one-on-one meetings held throughout the day. Management will discuss the company's progress including its recently filed Premarket Notification [510(k)] with the U.S. Food and Drug Administration for its AppyScore Test, the first blood-based test designed as an aid in the diagnosis of human appendicitis.

For more information about the conference or to schedule a one-on-one meeting with the company, contact your Canaccord Adams institutional sales representative.

About Canaccord Adams, Inc.

Canaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients a unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, its 225 professionals seek out emerging opportunities in key sectors -- mining and metals, energy, technology, life sciences, consumer, real estate, sustainability and infrastructure. Located in ten offices internationally, its experienced team generates focused, actionable ideas that identify opportunity and facilitate growth. Canaccord Adams, the international capital markets division of Canaccord Capital Inc., has operations in Toronto, London, Boston, Vancouver, New York, Calgary, San Francisco, and Houston. More information is available at [ www.canaccordadams.com ].

About AspenBio Pharma, Inc.

AspenBio Pharma's mission is to be a leader in the development and commercialization of innovative products that address unmet diagnostic and therapeutic needs in both Human and Animal Health. Our Human Health Division is addressing the difficult challenge of diagnosing appendicitis in the hospital emergency department setting. Our Animal Health Division is focused on therapeutic proteins that support reproductive efficiency in non-companion animals of economic importance. For more information, go to [ www.aspenbiopharma.com ].


Publication Contributing Sources

Similar Health and Fitness Publications